Healthcare Equipment and Supplies
Company Overview of Aptus Endosystems, Inc.
Aptus Endosystems, Inc., a medical device company, develops a helical anchor technology that allows physicians to perform abdominal aortic aneurysms and thoracic endovascular aneurysm repairs for patients. The company offers Heli-FX endoanchor system, a mechanical fastening device to enhance an endograft’s inherent fixation and sealing mechanisms; and Heli-FX thoracic endoanchor system, a longer delivery device to enhance the long term durability of thoracic endovascular aneurysm repairs. It serves customers in the United States and Europe. The company was founded in 2002 and is based in Sunnyvale, California.
271 Gibraltar Drive
Sunnyvale, CA 94089
Founded in 2002
Key Executives for Aptus Endosystems, Inc.
Co-Founder and Chairman of the Board
Chief Financial Officer and Vice President of Finance
Compensation as of Fiscal Year 2014.
Aptus Endosystems, Inc. Key Developments
Aptus Endosystems, Inc. Enters into an Agreement with Maquet (Getinge Group) for Distribution of Its Products in the United Kingdom and Ireland
Nov 18 14
Aptus Endosystems, Inc. announced that it has entered into an agreement with Maquet (Getinge Group) for distribution of its products in the United Kingdom and Ireland. Maquet’s Vascular Systems and Cardiac Surgery group will market and sell the Aptus Heli-FX EndoAnchor System and the Heli-FX Thoracic EndoAnchor System for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), respectively. The Heli-FX EndoAnchor System, developed and manufactured by Aptus, consists of a catheter based delivery system and implantable helical screws (EndoAnchors) that lock the endograft to the aortic vessel. The EndoAnchor is designed to provide enhanced seal and fixation, similar to the stability achieved by hand suturing during open surgical repair of an aneurysm. The Heli-FX System can be used upon implantation of the endograft to enhance its inherent fixation and sealing mechanisms. The system can also be used to repair endovascular grafts that have developed endoleaks, migrated away from the implant site, or are at risk of developing these complications, which are frequently seen after EVAR.
Aptus Endosystems, Inc. Presents at Emerging Medical Technologies Summit, Nov-11-2014 08:40 AM
Nov 10 14
Aptus Endosystems, Inc. Presents at Emerging Medical Technologies Summit, Nov-11-2014 08:40 AM. Venue: Sofitel Hotel San Francisco, 223 Twin Dolphin Dr., Redwood City, CA 94065, United States.
Aptus Endosystems Appoints Lyons as Vice President, Global Marketing
May 23 14
Aptus Endosystems, Inc. announced that it has appointed Ruth Lyons to the position of Vice President, Global Marketing. Lyons will lead all global marketing activities and drive business strategy development and execution. Lyons has more than 25 years in medical device marketing with companies and market-changing products. Lyons comes to Aptus with a wealth of experience in cardiac-related clinical specialties. She has held senior marketing and sales roles with Baxter Healthcare and Johnson & Johnson.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|